Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-09-09 | Dr. Rupert Vessey, MA, BM BCh, FRCP, DPhil, is currently the President of Global Research and Early Development at Celgene, and is anticipated to hold that position at Bristol-Myers Squibb once its acquisition of Celgene is final. While at Celgene, Dr. Vessey also served on the board of Juno Therapeutics from April 2017 until its acquisition by Celgene in March of 2018. Before joining Celgene, Dr. Vessey held various research and development senior management positions at Merck. Dr. Vessey holds an MA in physiological sciences and a BM BCh in clinical medicine from Oxford University where he completed his DPhil at the Institute for Molecular Medicine, Oxford along with additional clinical training at various hospitals in the UK. He is a member of the Royal College of Physicians of London UK. He also serves on the Board of privately held therapeutics company Pharmakea. Director Compensation for FY 2019 Rupert Vessey, MA, BM BCh, FRCP, DPhi Total: $61,548 |
| 2020-09-15 | Dr. Rupert Vessey, MA, BM BCh, FRCP, DPhil Age: 55 Independent Director Since: 2019 Member of Executive Compensation and Nominations & Governance Committees Director Compensation for FY 2020: $335,190 |
| 2024-09-12 | Rupert Vessey, MA, BM BCh, FRCP, DPhil Age: 59 Director since: 2019 INDEPENDENT Committees: Compensation Science & Technology ...Dr. Vessey joined Flagship Pioneering as Executive Partner and Chief Scientist in July 2023. ...Compensation Paid to the Non-Employee Directors Rupert Vessey Fees Earned or Paid in Cash: $75,000 Stock Awards: $99,954 Option Awards: $100,010 All Other Compensation: $498 Total: $275,462 |
Data sourced from SEC filings. Last updated: 2026-02-03